Three-time bladder cancer survivor from south Staffordshire backs landmark trial

Brenda Irving has beaten the disease three times and is urging people to be part of research.

A south Staffordshire grandmother who has beaten bladder cancer three times has urged people to be part of research after joining a national study looking at a less invasive way to detect the disease.

Security guard Brenda Irving, from Essington, had a tumour removed on each occasion after they were discovered, having all her treatment at Wolverhampton’s New Cross Hospital.

The mum of three and grandmother of five was one of 4,616 people across England who joined BC-Recon, a study supported by the National Institute for Health and Care Research (NIHR) into the effectiveness of a urine test, instead of using a camera inspecting the bladder.

Known as a flexi cystoscopy, it can be uncomfortable, embarrassing and result in complications.

The 60-year-old said: “It was explained to me that they were trying to find a way to test that was less invasive.

Brenda Irving has urged people to be part of research around Bladder cancer. Photo: NIHRplaceholder image
Brenda Irving has urged people to be part of research around Bladder cancer. Photo: NIHR | NIHR

“All I had to do was give a sample, so I took the kit home, did it, labelled it up and sent it back through the post.

“It was so easy and not invasive and it was a lot quicker than waiting in hospital. I’d definitely do it again if I was asked because it’s so quick.

“If anyone is asked to do this I would tell them to do it. If that’s all you have to do then more people might come forward to get checked.

“The staff were friendly, professional and made me feel at ease. I had everything explained to me.”

Brenda said she has now received two clear tests, so is cancer free, and is now only tested yearly after previous six-monthly check-ups.

The BC-Recon team pose outside the unit at New Cross Hospital. Photo: NIHRplaceholder image
The BC-Recon team pose outside the unit at New Cross Hospital. Photo: NIHR | NIHR

University of Birmingham researchers, funded by Cancer Research UK, developed a urine test identifying the mutated DNA which comes from bladder cancer.

If proven accurate enough, the new test might be rolled out so some patients might be able to avoid a cystoscopy.

National Institute for Health and Care Research funding provided two staff at New Cross Hospital, Alison Bland, Research Nurse, and Yasmin Hussain, RDN Agile Research Delivery Team Team Manager, for more than six months to recruit volunteers to the study.

They signed up most of the 547 participants at the hospital, which is part of The Royal Wolverhampton NHS Trust (RWT).

Mr David Mak, Consultant Robotic and Urological Surgeon at RWT and Principal Investigator on BC-Recon, said: “The support provided through the NIHR RDN was instrumental to the success of BC-Recon at New Cross Hospital.

“Without this support, delivering the study at this scale would have been extremely challenging alongside routine NHS services.”

Comment Guidelines

Iconic Media encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.

Local news you can trust
Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice